Brief: Bioretec Gets FDA Breakthrough Device Designation Status For Remeos Spinal Interbody Cage

Bioretec Oy

14/03/2024 14:19

March 14 (Reuters) - Bioretec Oy  BRETEC.HE :
    * BIORETEC HAS BEEN GRANTED FDA BREAKTHROUGH DEVICE
DESIGNATION
STATUS FOR ITS REMEOS™ SPINAL INTERBODY CAGE

Source text for Eikon:  ID:nWkr78ShM3 
Further company coverage:  BRETEC.HE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))